medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2025-11-65-67medalphabet-4429Research ArticleСтатьиПерспективы морфологического ультрастадирования в онкогинекологииProspects of morphological ultra-staging in gynecological oncologyhttps://orcid.org/0009-0007-8377-9601ХакимовГ. А.KhakimovG. A.

Хакимов Голиб Абдуллоевич - д.м.н., проф., директор Ташкентский городской филиал Республиканского специализированного НПМЦ онкологии и радиологии, зав. кафедрой детской онкологии, паллиативной помощи Ташкентского педиатрического медицинского института.

Ташкент

Khakimov Golib A. - DM Sci (habil.), professor, director Tashkent city branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, head of Department of Pediatric Oncology, Palliative Care, Tashkent pediatric medical institute.

Tashkent

golib_khakimov@mail.ruhttps://orcid.org/0000-0002-4970-5429ХакимоваГ. Г.KhakimovaG. G.

Хакимова Гулноз Голибовна - к.м.н., доцент кафедры детской онкологии, паллиативной помощи Ташкентского педиатрического медицинского института, онколог-химиотерапевт Ташкентский городской филиал Республиканского специализированного НПМЦ онкологии и радиологии.

Ташкент

Khakimova Gulnoz G. - PhD Med, associate professor at Department of Pediatric Oncology, Palliative Care, Tashkent pediatric medical institute, medical oncologist Tashkent city branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology.

Tashkent

hgg_doc@mail.ruСабироваС. А.SabirovaS. A.

Сабирова Салтанат Абдуллаевна - онколог-гинеколог.

Ташкент

Sabirova Saltanat A - oncologist gynecologist.

Tashkent

sagusha89@mail.ruhttps://orcid.org/0000-0002-2329-6989МамаджановХ. И.MamadjanovH. I.

Мамаджанов Хасан Икрамович - онколог-гинеколог.

Ташкент

Mamadjanov Khasan I. - oncologist gynecologist.

Tashkent

hasanmamajanov03@gmail.comhttps://orcid.org/0009-0001-7904-6989ЭркиноваШ. И.ErkinovaS. I.

Эркинова Ширина Искандаровна – студентка.

Ташкент

Erkinova Shirina I. - a student.

Tashkent

sirinerlinova@gmail.comТашкентский городской филиал Республиканского специализированного научно-практического медицинского центра онкологии и радиологии; Ташкентский педиатрический медицинский институтУзбекистанTashkent city branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and RadiologyUzbekistanТашкентский городской филиал Республиканского специализированного научно-практического медицинского центра онкологии и радиологииУзбекистанTashkent city branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and RadiologyUzbekistanТашкентская медицинская академияУзбекистанTashkent Medical AcademyUzbekistan202503072025011«Диагностика и онкотерапия» (1)6567Copyright © Хакимов Г.А., Хакимова Г.Г., Сабирова С.А., Мамаджанов Х.И., Эркинова Ш.И., 20252025Хакимов Г.А., Хакимова Г.Г., Сабирова С.А., Мамаджанов Х.И., Эркинова Ш.И.Khakimov G.A., Khakimova G.G., Sabirova S.A., Mamadjanov H.I., Erkinova S.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/4429

Состояние лимфатических узлов является важным прогностическим фактором и критерием для проведения адъювантной терапии при злокачественных новообразованиях (ЗНО). В то время как обнаружение микрометастазов с помощью методов ультрастадирования коррелирует с прогнозом при ряде ЗНО и является частью стандартного лечения пациентов с гематологическими злокачественными новообразованиями, в случае рака шейки матки и рака эндометрия остаются противоречия. В случаях таких нозологий, как рак матки, рак молочной железы и рак толстой кишки, это остается предметом дискуссий. Целью данного обзора является значимость ультрастадирования сторожевого лимфатического узла (СЛУ) при оценке выбора тактики лечения и снижении риска локорегионального рецидива.

The condition of the lymph nodes is a mandatory prognostic sign and criterion for adjuvant therapy for malignant neoplasms (MN). While micrometastases have been found to correlate with prognosis in a number of cancers using ultrastaging techniques and are part of the standard treatment for patients with hematologic malignancies, controversy remains in the case of cervical cancer and endometrium cancer. The purpose of this review is the novelty of sentinel lymph node (SLN) ultrastaging in guiding treatment decisions and reducing the risk of regional recurrence.

ультрастадированиеиммуногистохимиярак шейки маткигематоксилин эозинultrastagingimmunohistochemistrycervical cancerhematoxylin eosinReferencesBézu C., Coutant C., Ballester M. et al. Ultrastaging of lymph node in uterine cancers. J. Exp. Clin. Cancer. Res. 2010; 29: 5. https://doi.org/10.1186/1756-9966-29-5Bézu C., Coutant C., Ballester M. et al. Ultrastaging of lymph node in uterine cancers. J. Exp. Clin. Cancer. Res. 2010; 29: 5. https://doi.org/10.1186/1756-9966-29-5Frumovitz M., Sun C. C., Schmeler K. M., Deavers M. T., dos Reis R., Levenback C. F., Ramirez P. T. Parametrial Involvement in Radical Hysterectomy Specimens for Women with Early-Stage Cervical Cancer. Obstet. Gynecol. 2009; 114: 93–99. DOI: 10.1097/AOG.0b013e3181ab474dFrumovitz M., Sun C. C., Schmeler K. M., Deavers M. T., dos Reis R., Levenback C. F., Ramirez P. T. Parametrial Involvement in Radical Hysterectomy Specimens for Women with Early-Stage Cervical Cancer. Obstet. Gynecol. 2009; 114: 93–99. DOI: 10.1097/AOG.0b013e3181ab474dLi C., Yang S., Hua K. Nomogram Predicting Parametrial Involvement Based on the Radical Hysterectomy Specimens in the Early-Stage Cervical Cancer. Front. Surg. 2021; 8: 759026. DOI: 10.3389/fsurg.2021.759026Li C., Yang S., Hua K. Nomogram Predicting Parametrial Involvement Based on the Radical Hysterectomy Specimens in the Early-Stage Cervical Cancer. Front. Surg. 2021; 8: 759026. DOI: 10.3389/fsurg.2021.759026Wright J. D., Grigsby P. W., Brooks R., Powell M. A., Gibb R. K., Gao F., Rader J. S., Mutch D. G. Utility of parametrectomy for early-stage cervical cancer treated with radical hysterectomy. Cancer. 2007; 110: 1281–1286. DOI: 10.1002/cncr.22899Wright J. D., Grigsby P. W., Brooks R., Powell M. A., Gibb R. K., Gao F., Rader J. S., Mutch D. G. Utility of parametrectomy for early-stage cervical cancer treated with radical hysterectomy. Cancer. 2007; 110: 1281–1286. DOI: 10.1002/cncr.22899Colpaert C., Jacomen G., Van de Vijver K., Baldewijns M., Van Rompuy A. S., Bourgain C., Noël J. C. Belgian Working Group for Gynecological Pathology. Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer? Letter to the editor, Reply to Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. Gynecol. Oncol. 2019; 152: 202–7.Colpaert C., Jacomen G., Van de Vijver K., Baldewijns M., Van Rompuy A. S., Bourgain C., Noël J. C. Belgian Working Group for Gynecological Pathology. Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer? Letter to the editor, Reply to Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. Gynecol. Oncol. 2019; 152: 202–7.Cibula D., McCluggage W. G. Sentinel lymph node (SLN) concept in cervical cancer: current limitations and unanswered questions. Gynecol. Oncol. 2019; 152: 202–207.Cibula D., McCluggage W. G. Sentinel lymph node (SLN) concept in cervical cancer: current limitations and unanswered questions. Gynecol. Oncol. 2019; 152: 202–207.Cibula D., Abu-Rustum N.R., Dusek L. et al. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol. Oncol. 2012; 124: 496–501.Cibula D., Abu-Rustum N.R., Dusek L. et al. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol. Oncol. 2012; 124: 496–501.Winter R., Haas J., Reich O., Koemetter R., Tamussino K., Lahousen M., Petru E., Pickel H. Parametrial Spread of Cervical Cancer in Patients with Negative Pelvic Lymph Nodes. Gynecol. Oncol. 2002; 84: 252–257. DOI: 10.1006/gyno.2001.6495Winter R., Haas J., Reich O., Koemetter R., Tamussino K., Lahousen M., Petru E., Pickel H. Parametrial Spread of Cervical Cancer in Patients with Negative Pelvic Lymph Nodes. Gynecol. Oncol. 2002; 84: 252–257. DOI: 10.1006/gyno.2001.6495Euscher, Elizabeth D., Malpica, Anais, Atkinson, Edward Neely, Levenback, Charles F., Frumovitz, Michael, Deavers, Michael T. Ultrastaging Improves Detection of Metastases in Sentinel Lymph Nodes of Uterine Cervix Squamous Cell Carcinoma. The American Journal of Surgical Pathology. 2008; 32 (9): 1336–1343. DOI: 10.1097/PAS.0b013e31816ecfe4Euscher, Elizabeth D., Malpica, Anais, Atkinson, Edward Neely, Levenback, Charles F., Frumovitz, Michael, Deavers, Michael T. Ultrastaging Improves Detection of Metastases in Sentinel Lymph Nodes of Uterine Cervix Squamous Cell Carcinoma. The American Journal of Surgical Pathology. 2008; 32 (9): 1336–1343. DOI: 10.1097/PAS.0b013e31816ecfe4Lührs O., Ekdahl L., Geppert B., Lönnerfors C., Persson J. Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early-stage cervical cancer. Gynecol. Oncol. 2021; 163: 289–293. DOI: 10.1016/j.ygyno.2021.08.031Lührs O., Ekdahl L., Geppert B., Lönnerfors C., Persson J. Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early-stage cervical cancer. Gynecol. Oncol. 2021; 163: 289–293. DOI: 10.1016/j.ygyno.2021.08.031Balaya V., Bresset A., Guani B., Benoit L., Magaud L., Bonsang-Kitzis H., Ngo C., Mathevet P., Lécuru F. SENTICOL group pre-operative surgical algorithm: Sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer. Int. J. Gynecol. Cancer. 2020; 30: 1317–1325. Doi: 10.1136/ijgc-2020-001586Balaya V., Bresset A., Guani B., Benoit L., Magaud L., Bonsang-Kitzis H., Ngo C., Mathevet P., Lécuru F. SENTICOL group pre-operative surgical algorithm: Sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer. Int. J. Gynecol. Cancer. 2020; 30: 1317–1325. Doi: 10.1136/ijgc-2020-001586Bizzarri N., Arciuolo D., Certelli C., Pedone Anchora L., Gallotta V., Teodorico E., Carbone M. V., Piermattei A., Fanfani F., Fagotti A., Ferrandina G., Zannoni G. F., Scambia G., Querleu D. Ultrastaging of the Parametrium in Cervical Cancer: A Clinicopathological Study. Cancers (Basel). 2023; 15 (4): 1099. DOI: 10.3390/cancers15041099Bizzarri N., Arciuolo D., Certelli C., Pedone Anchora L., Gallotta V., Teodorico E., Carbone M. V., Piermattei A., Fanfani F., Fagotti A., Ferrandina G., Zannoni G. F., Scambia G., Querleu D. Ultrastaging of the Parametrium in Cervical Cancer: A Clinicopathological Study. Cancers (Basel). 2023; 15 (4): 1099. DOI: 10.3390/cancers15041099Ferrandina G., Anchora L. P., Gallotta V., Fagotti A., Vizza E., Chiantera V., DE Iaco P., Ercoli A., Corrado G., Bottoni C. et al. Can We Define the Risk of Lymph Node Metastasis in Early-Stage Cervical Cancer Patients? A Large-Scale, Retrospective Study. Ann. Surg. Oncol. 2017; 24: 2311–2318. DOI: 10.1245/s10434-017-5917-0Ferrandina G., Anchora L. P., Gallotta V., Fagotti A., Vizza E., Chiantera V., DE Iaco P., Ercoli A., Corrado G., Bottoni C. et al. Can We Define the Risk of Lymph Node Metastasis in Early-Stage Cervical Cancer Patients? A Large-Scale, Retrospective Study. Ann. Surg. Oncol. 2017; 24: 2311–2318. DOI: 10.1245/s10434-017-5917-0Bodurtha Smith A. J., Fader A. N., Tanner E. J. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2017; 216 (5): 459–476.e10. DOI: 10.1016/j.ajog.2016.11.1033Bodurtha Smith A. J., Fader A. N., Tanner E. J. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2017; 216 (5): 459–476.e10. DOI: 10.1016/j.ajog.2016.11.1033Burg L. C., Hengeveld E. M., in ‘t Hou J. et al. Ultrastaging methods of sentinel lymph nodes in endometrial cancer – a systematic review. International Journal of Gynecologic Cancer. 2021; 31: 744–753.Burg L. C., Hengeveld E. M., in ‘t Hou J. et al. Ultrastaging methods of sentinel lymph nodes in endometrial cancer – a systematic review. International Journal of Gynecologic Cancer. 2021; 31: 744–753.Todo Y., Kato H., Okamoto K., Minobe S., Yamashiro K., Sakuragi N. Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer. J. Gynecol. Oncol. 2015; 27 (1): 23–28.Todo Y., Kato H., Okamoto K., Minobe S., Yamashiro K., Sakuragi N. Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer. J. Gynecol. Oncol. 2015; 27 (1): 23–28.Kim C. H., Soslow R. A., Park K. J., Barber E. L., Khoury-Collado F., Barlin J. N., Sonoda Y., Hensley M. L., Barakat R. R., Abu-Rustum N. R. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J. Gynecol. Cancer. 2013 Jun; 23 (5): 964–70. DOI: 10.1097/IGC.0b013e3182954da8Kim C. H., Soslow R. A., Park K. J., Barber E. L., Khoury-Collado F., Barlin J. N., Sonoda Y., Hensley M. L., Barakat R. R., Abu-Rustum N. R. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J. Gynecol. Cancer. 2013 Jun; 23 (5): 964–70. DOI: 10.1097/IGC.0b013e3182954da8Holub Z. et al. Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. Medical science monitor: international medical journal of experimental and clinical research. 2004; 10 (10): 587–91.Holub Z. et al. Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. Medical science monitor: international medical journal of experimental and clinical research. 2004; 10 (10): 587–91.Raspagliesi F. et al. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. American journal of obstetrics and gynecology. 2004; 191 (2): 435–439.Raspagliesi F. et al. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. American journal of obstetrics and gynecology. 2004; 191 (2): 435–439.Altgassen C. et al. A new approach to label sentinel nodes in endometrial cancer. Gynecologic oncology. 2007; 105 (2): 457–461.Altgassen C. et al. A new approach to label sentinel nodes in endometrial cancer. Gynecologic oncology. 2007; 105 (2): 457–461.Frumovitz M. et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecologic oncology. 2007; 104 (1): 100–103.Frumovitz M. et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecologic oncology. 2007; 104 (1): 100–103.Li B. et al. A pilot study of sentinel lymph nodes identification in patients with endometrial cancer. Bulletin du Cancer. 2007; 94 (1): 10001–10004.Li B. et al. A pilot study of sentinel lymph nodes identification in patients with endometrial cancer. Bulletin du Cancer. 2007; 94 (1): 10001–10004.Niikura H. et al. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecologic oncology. 2007; 105 (3): 683–686.Niikura H. et al. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecologic oncology. 2007; 105 (3): 683–686.Pelosi E. et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early-stage endometrial cancer. Nuclear medicine communications. 2003; 24 (9): 971–975.Pelosi E. et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early-stage endometrial cancer. Nuclear medicine communications. 2003; 24 (9): 971–975.Delpech Y. et al. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Annals of oncology. 2007; 18 (11): 1799–1803.Delpech Y. et al. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Annals of oncology. 2007; 18 (11): 1799–1803.Maccauro M. et al. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99m Tc-labelled albumin nanocolloid in endometrial cancer. European journal of nuclear medicine and molecular imaging. 2005; 32: 569–574.Maccauro M. et al. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99m Tc-labelled albumin nanocolloid in endometrial cancer. European journal of nuclear medicine and molecular imaging. 2005; 32: 569–574.Delaloye J. F. et al. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecologic oncology. 2007; 106 (1): 89–93.Delaloye J. F. et al. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecologic oncology. 2007; 106 (1): 89–93.Lopes L. A.F. et al. Sentinel lymph node in endometrial cancer. International Journal of Gynecologic Cancer. 2007; 17 (5): 1113–7.Lopes L. A.F. et al. Sentinel lymph node in endometrial cancer. International Journal of Gynecologic Cancer. 2007; 17 (5): 1113–7.Ballester M. et al. Use of the sentinel node procedure to stage endometrial cancer. Annals of Surgical Oncology. 2008; 15: 1523–1529.Ballester M. et al. Use of the sentinel node procedure to stage endometrial cancer. Annals of Surgical Oncology. 2008; 15: 1523–1529.Bats A. S. et al. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. Journal of surgical oncology. 2008; 97 (2): 141–145.Bats A. S. et al. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. Journal of surgical oncology. 2008; 97 (2): 141–145.

The authors declare that there are no conflicts of interest present.